EUVIMEDEUVIMED entdecken
Crossref

UCHL1 acts as a prognostic factor and promotes cancer stemness in cervical squamous cell carcinoma

Qingge Jia, Hongjie Wang, Xin Xiao, Yameng Sun, Xiao Tan, Jia Chai, Yanru Yang, Zhiyong Yin, Mingyang Li, Ke Wang, Jin Liu

Pathology - Research and Practice · 2023-07 · 247 · 154574

DOI: 10.1016/j.prp.2023.154574 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathology - Research and Practice, 2023-07. Verfasst von Qingge Jia und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Reproductive Endocrinology, Xi'an International Medical Center Hospital, Northwest University, Xi'an, China. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Uterine Cervical Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Key Research and Development Projects of Shaanxi Province, National Natural Science Foundation of China, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The incidence and death rate of cervical cancer rank fourth among female malignant tumors worldwide. A growing number of researches are devoted to exploring more effective treatment methods and cancer stem cells (CSCs) are thought to be a potential therapeutic target in cervical cancer. In our study, we focused on the expression and function of UCHL1 in cervical squamous cell carcinoma (CESC). METHODS: We detected and the expression of UCHL1 in 134 CESC patients through immunohistochemistry and further confirm UCHL1 was a prognostic factor by univariate and multivariate analysis. Then, according to TCGA database for CESC, we found that UCHL1 expression correlated with the markers associated with CSCs (CD133, ABCG2 and SOX2). Therefore, we used western blot and spheroid formation assays to future evaluate the function of UCHL1 on cancer stemness in C-33A and SiHa cell lines. At the same time, we detected the cell proliferation, migration and invasion change by CCK-8 assay, scratch assay and transwell assay, when UCHL1 was knockdown or overexpressed. Finally, xenograft models were used to examine the effect of UCHL1 in vivo. RESULTS: We found the expression of UCHL1 in mRNA and protein was higher in tumor than in paired normal tissue and was a prognostic factor in CESC. The UCHL1 high expression group showed a shorter survival in the overall survival. According to TCGA database, the expression of UCHL1 was correlated with CD133, ABCG2 and SOX2. The results of sphere-forming ability and CSCs related markers expression were showed UCHL1 promoted cancer stemness in CESC. Similarly, CCK-8 assay, scratch assay and transwell assay were applied to demonstrate that overexpression of UCHL1 promoted the proliferation, migration and invasion in SiHa, but when UCHL1 was knockdown in C-33A, the function of UCHL1 displayed the opposite result. Finally, knockdown UCHL1 inhibited CESC tumor propagation in xenograft models. CONCLUSION: Our results suggest that UCHL1 is a prognostic factor and correlated with cancer stemness, proliferation, migration and invasion of CESC, which may provide a novel therapeutic strategy for CESC treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Squamous CellUterine Cervical NeoplasmsFemaleHumansCell Line, TumorCell ProliferationPrognosisUbiquitin Thiolesterase

Stichwörter der Autor:innen

CESCCancer stem cellsMigrationPrognosisUCHL1

Substanzen

Ubiquitin ThiolesteraseUCHL1 protein, human

Autor:innen und Institutionen

  • Department of Reproductive Endocrinology, Xi'an International Medical Center Hospital, Northwest University, Xi'an, China.
  • Department of Military and Special medicine, No. 971 Hospital of the PLA Navy, Qingdao, China.
  • Center of Medical Security, No. 971 Hospital of the PLA Navy, Qingdao, China.
  • State Key Laboratory of Cancer Biology, Department of Pathology, Xijing Hospital and School of Basic Medicine, Fourth Military Medical University, Xi'an, China.
  • Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi'an, China. Electronic address: zhiyong_yin@163.com.
  • State Key Laboratory of Cancer Biology, Department of Pathology, Xijing Hospital and School of Basic Medicine, Fourth Military Medical University, Xi'an, China. Electronic address: limingyang1108@sina.com.

Förderung

  • Key Research and Development Projects of Shaanxi Province
  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation

Zitieren

APA

Jia, Q., Wang, H., Xiao, X., Sun, Y., Tan, X., Chai, J., Yang, Y., Yin, Z., Li, M., Wang, K., & Liu, J. (2023). UCHL1 acts as a prognostic factor and promotes cancer stemness in cervical squamous cell carcinoma. Pathology - Research and Practice, 247, 154574. https://doi.org/10.1016/j.prp.2023.154574

Vancouver

Jia Q, Wang H, Xiao X, Sun Y, Tan X, Chai J, et al. UCHL1 acts as a prognostic factor and promotes cancer stemness in cervical squamous cell carcinoma. Pathology - Research and Practice. 2023;247:154574. doi:10.1016/j.prp.2023.154574

BibTeX
@article{Jia2023,
  author = {Jia, Qingge and Wang, Hongjie and Xiao, Xin and Sun, Yameng and Tan, Xiao and Chai, Jia and Yang, Yanru and Yin, Zhiyong and Li, Mingyang and Wang, Ke and Liu, Jin},
  title = {UCHL1 acts as a prognostic factor and promotes cancer stemness in cervical squamous cell carcinoma},
  journal = {Pathology - Research and Practice},
  year = {2023},
  volume = {247},
  pages = {154574},
  doi = {10.1016/j.prp.2023.154574}
}
Kostenlos starten →